Tag: GSK

LONDON (Reuters) – The world’s leading drug companies are turning to artificial intelligence to improve the hit-and-miss business of finding new medicines, with GlaxoSmithKline unveiling a new $43 million deal in the field on Sunday. Other pharmaceutical giants including Merck & Co, Johnson & Johnson and Sanofi are also exploring the potential of artificial intelligence […]

LONDON (Reuters) – The line between pharmaceuticals and technology is blurring as companies join forces to tackle chronic diseases using high-tech devices that combine biology, software and hardware. GlaxoSmithKline and Google parent Alphabet are the latest to share expertise, unveiling a new joint company on Monday that aims to market bioelectronic devices to fight illness […]
Recent Comments